Nov. 16, 2023
The Centers for Medicare and Medicaid Services (CMS) recently updated the FAQ for the use of JW and JZ modifiers. Beginning Oct. 1, CMS required the use of JW and JZ modifiers for all claims for drugs from single-use vials or single-use packages payable separately under Medicare Part B. The JW modifier is used to identify any discarded amounts. The JZ modifier is used to attest that there were no discarded amounts. CMS also posted a (non-exhaustive) list of codes subject to the modifier policy.

The American College of Radiology®(ACR®), the Radiology Business Management Association, RadNet, and RayUS met with CMS in September and advocated for the exclusion of imaging contrast agents and radiopharmaceuticals from the JW/JZ reporting requirement. CMS did however indicate the list likely will be updated semi-annually with newly identified codes.

If you have any questions, contact Christina Berry, ACR Team Lead, Economic Policy.

Related ACR News

  • House Passes Budget Bill With Expanded Funding

    The bill includes a provision to add $9 billion in new spending to the MPFS via an inflation-based update to the conversion factor.

    Read more
  • State Legislation Update

    ACR tracks hundreds of healthcare-related bills each state legislative cycle.

    Read more
  • CDC Alert: Use Only Sterile Ultrasound Gel for Percutaneous Procedures

    The Centers for Disease Control and Prevention (CDC) alerted healthcare facilities about non-sterile ultrasound gel products.

    Read more